MaxCyte Inc (NASDAQ:MXCT) has seen 1.44 million shares traded in the recent trading session. The company, currently valued at $222.74M, closed the recent trade at $2.1 per share which meant it lost -$0.11 on the day or -5.42% during that session. The MXCT stock price is -147.62% off its 52-week high price of $5.20 and 4.29% above the 52-week low of $2.01. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.76 million shares traded. The 3-month trading volume is 881.47K shares.
The consensus among analysts is that MaxCyte Inc (MXCT) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 2 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight.
MaxCyte Inc (NASDAQ:MXCT) trade information
Sporting -5.42% in the red today, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the MXCT stock price touched $2.1 or saw a rise of 7.08%. Year-to-date, MaxCyte Inc shares have moved -50.59%, while the 5-day performance has seen it change -2.56%. Over the past 30 days, the shares of MaxCyte Inc (NASDAQ:MXCT) have changed -4.34%. Short interest in the company has seen 3.54 million shares shorted with days to cover at 2.89.
Wall Street analysts have a consensus price target for the stock at $6, which means that the shares’ value could jump 65.0% from the levels at last check today.. The projected low price target is $6.0 while the price target rests at a high of $6.0. In that case, then, we find that the latest price level in today’s session is -185.71% off the targeted high while a plunge would see the stock gain -185.71% from the levels at last check today..
MaxCyte Inc (MXCT) estimates and forecasts
The company’s shares have lost -49.40% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -11.37% over the past 5 years. Earnings growth for 2025 is a modest 8.54% while over the next 5 years, the company’s earnings are expected to increase by 9.79%.
MXCT Dividends
MaxCyte Inc is expected to release its next earnings report on 2025-May-08 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
MaxCyte Inc (NASDAQ:MXCT)’s Major holders
Insiders own 1.40% of the company shares, while shares held by institutions stand at 75.79% with a share float percentage of 76.86%. Investors are also buoyed by the number of investors in a company, with MaxCyte Inc having a total of 166.0 institutions that hold shares in the company. The top two institutional holders are BLACKROCK INC. with over 8.14 million shares worth more than $31.92 million. As of 2024-06-30, BLACKROCK INC. held 7.7814% of shares outstanding.
The other major institutional holder is CADIAN CAPITAL MANAGEMENT, LP, with the holding of over 7.62 million shares as of 2024-06-30. The firm’s total holdings are worth over $29.88 million and represent 7.285% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . As of Mar 31, 2025 , the former fund manager holds about 2.64% shares in the company for having 2.81 shares of worth $5.9 million while later fund manager owns 2.58 shares of worth $5.42 million as of Apr 30, 2025 , which makes it owner of about 2.43% of company’s outstanding stock.
